Trial
NCT02834793
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Eisai Inc.
Collaborators
—
Condition
Lennox-Gastaut Syndrome (LGS)
Intervention
Placebo
Why stopped
Sponsor's decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-09